Heike Reinhardt

922 total citations
24 papers, 549 citations indexed

About

Heike Reinhardt is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Heike Reinhardt has authored 24 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Heike Reinhardt's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (7 papers) and Cancer Treatment and Pharmacology (5 papers). Heike Reinhardt is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (7 papers) and Cancer Treatment and Pharmacology (5 papers). Heike Reinhardt collaborates with scholars based in Germany, Switzerland and United Kingdom. Heike Reinhardt's co-authors include Ralph Wäsch, Monika Engelhardt, Gabriele Ihorst, Martin Schumacher, Alexander Zober, Stefanie Hieke, Martina Kleber, Ola Landgren, Sandra Maria Dold and Stefan J. Müller and has published in prestigious journals such as Blood, Cancer and Cancers.

In The Last Decade

Heike Reinhardt

20 papers receiving 537 citations

Peers

Countries citing papers authored by Heike Reinhardt

Since Specialization

Citations

This map shows the geographic impact of Heike Reinhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Reinhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Reinhardt more than expected).

Fields of papers citing papers by Heike Reinhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Reinhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Reinhardt. The network helps show where Heike Reinhardt may publish in the future.

Co-authorship network of co-authors of Heike Reinhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Reinhardt. A scholar is included among the top collaborators of Heike Reinhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Reinhardt. Heike Reinhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)—multicenter real-world analysis from Germany and comparative review of the literature 2025 ·Annals of Hematology ·(unknown), (unknown), Heike Reinhardt, (unknown), Gabriele Ihorst, (unknown), (unknown), Annamaria Brioli, Marie von Lilienfeld‐Toal, (unknown), (unknown), Markus Munder, (unknown), Karolin Trautmann‐Grill, Sarah Decker, (unknown), (unknown), Monika Engelhardt	0
2	Optimizing individualized therapy decision-making in multiple myeloma (MM): integration and impact of the Revised Myeloma Comorbidity Index in the MM-tumor board 2024 ·Annals of Hematology ·(unknown), Gabriele Ihorst, Heike Reinhardt, (unknown), (unknown), Georg W. Herget, Christine Greil, Ralph Wäsch, (unknown)	2
3	An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence 2022 ·Haematologica ·(unknown), Gabriele Ihorst, Heike Reinhardt, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ralph Wäsch, Monika Engelhardt	5
4	Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort 2021 ·Cancer ·(unknown), Gabriele Ihorst, (unknown), (unknown), (unknown), Heike Reinhardt, Ralph Wäsch, Monika Engelhardt	14
5	Avoiding chemotherapy prescribing errors: Analysis and innovative strategies 2019 ·Cancer ·Heike Reinhardt, (unknown), (unknown), (unknown), Stefan Wöhrl, (unknown), Justus Duyster, Manfred Jung, Martin J. Hug, Monika Engelhardt	23
6	Pomalidomide 2018 ·Recent results in cancer research ·Monika Engelhardt, (unknown), Heike Reinhardt, Stefan J. Müller, Sandra Maria Dold, Ralph Wäsch	9
7	Osteoprotective medication in the era of novel agents: a European perspective on values, risks and future solutions 2018 ·Haematologica ·Monika Engelhardt, Georg W. Herget, Giulia Graziani, Gabriele Ihorst, Heike Reinhardt, (unknown), Stefan Knop, Ralph Wäsch	5
8	GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study 2018 ·Clinical and Experimental Nephrology ·Andrea Schmidts, Julian Grünewald, Martina Kleber, Evangelos Terpos, Gabriele Ihorst, Heike Reinhardt, Gerd Walz, Ralph Wäsch, Monika Engelhardt, Stefan Zschiedrich	0
9	Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach 2017 ·Journal of the National Comprehensive Cancer Network ·Heike Reinhardt, Rainer Trittler, (unknown), Stefan Wöhrl, Thomas Epting, Marion Buck, Sabine Kaiser, Daniel E Jonas, Justus Duyster, Manfred Jung, Martin J. Hug, Monika Engelhardt	11
10	A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients 2017 ·Haematologica ·Monika Engelhardt, (unknown), Sandra Maria Dold, Gabriele Ihorst, Heike Reinhardt, Alexander Zober, Stefanie Hieke, Corine Baayen, Stefan J. Müller, Hermann Einsele, Pieter Sonneveld, Ola Landgren, Martin Schumacher, Ralph Wäsch	174
11	Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores 2016 ·Haematologica ·Monika Engelhardt, (unknown), Gabriele Ihorst, Alexander Zober, Marco Möller, Heike Reinhardt, Stefanie Hieke, Martin Schumacher, Ralph Wäsch	121
12	Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years 2015 ·Haematologica ·(unknown), Gabriele Ihorst, Ola Landgren, Milena Pantić, Heike Reinhardt, Johannes M. Waldschmidt, Annette M. May, Martin Schumacher, Martina Kleber, Ralph Wäsch	35
13	Results of an Open, Non-Comparative, Phase I/II Investigator Initiated Trial (IIT) in Relapsed or Refractory Multiple Myeloma Patients Using Vorinostat, Bortezomib, Doxorubicin and Dexamethasone (VBDD) 2015 ·Blood ·Alexander Keller, Johannes M. Waldschmidt, Dagmar Wider, (unknown), (unknown), Heike Reinhardt, Milena Pantić, Olga Grishina, Gabriele Ihorst, Annette M. May, (unknown), (unknown), Justus Duyster, Manfred Jung, Monika Engelhardt, Ralph Wäsch	1
14	Vorinostat (V), bortezomib (B), doxorubicin (Dox) and dexamethasone (Dex, VBDD) in relapsed or refractory multiple myeloma patients (pts): results of an open, non-comparative, phase I/II investigator initiated trial (IIT) 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Alexander Keller, Johannes M. Waldschmidt, Dagmar Wider, (unknown), Marco Möller, Heike Reinhardt, Milena Pantić, Olga Grishina, Gabriele Ihorst, Annette M. May, (unknown), (unknown), Manfred Jung, Justus Duyster, Ralph Wäsch, Monika Engelhardt	0
15	Pomalidomide 2014 ·Recent results in cancer research ·Monika Engelhardt, Ralph Wäsch, Heike Reinhardt, Martina Kleber	14
16	Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Martina Kleber, Gabriele Ihorst, (unknown), Bernd Koch, Heike Reinhardt, Ralph Wäsch, Monika Engelhardt	63
17	Prevalence of Iron Overload Vs Iron Deficiency in Multiple Myeloma: Resembling or Different From MDS—and Stem Cell Transplant (SCT)—Patients? 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Christine König, Martina Kleber, Gabriele Ihorst, (unknown), Heike Reinhardt, Bernd Koch, Ralph Wäsch, Monika Engelhardt	8
18	Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients 2013 ·Annals of Hematology ·Christine König, Martina Kleber, Heike Reinhardt, Stefan Knop, Ralph Wäsch, Monika Engelhardt	27
19	CT/MRI-korrelierte Stereometrie mit Ultraschall für Hirnoperationen 2008 ·Ultraschall in der Medizin - European Journal of Ultrasound ·(unknown), Heike Reinhardt, (unknown), (unknown)	0
20	Polyvalent Influenza Vaccine: Comparison of Jet Injection with Intradermal and Subcutaneous Syringe Methods of Administration. 1965 ·Journal of Laboratory and Clinical Medicine ·M. L. Clark, Heike Reinhardt, (unknown), R. Alan Wilson	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact